These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 35564325)

  • 1. Properties of the Omicron Variant of SARS-CoV-2 Affect Public Health Measure Effectiveness in the COVID-19 Epidemic.
    Furuse Y
    Int J Environ Res Public Health; 2022 Apr; 19(9):. PubMed ID: 35564325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analyze the clinical characteristics of mild and severe SARS-CoV-2 infected patients based on the local Omicron variant epidemic].
    Yan Y; Lyu C; Davgadorj C; Wang X; Sha M
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Jan; 35(1):32-36. PubMed ID: 36880235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.
    Chung HY; Jian MJ; Chang CK; Lin JC; Yeh KM; Chen CW; Hsieh SS; Hung KS; Tang SH; Perng CL; Chang FY; Wang CH; Shang HS
    Microbiol Spectr; 2022 Feb; 10(1):e0251321. PubMed ID: 35196812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance Evaluation of Five Rapid At-Home COVID-19 Antigen Tests against the Omicron Variant.
    Sugiharto VA; Gatrell SK; Chen HW; Blazek GR; Cherry AM; Schilling M
    Microbiol Spectr; 2023 Feb; 11(1):e0228622. PubMed ID: 36519888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 vaccination and SARS-CoV-2 Omicron (B.1.1.529) variant: a light at the end of the tunnel?
    Mattiuzzi C; Henry BM; Lippi G
    Int J Infect Dis; 2022 May; 118():167-168. PubMed ID: 35278677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paediatric hospitalisations due to COVID-19 during the first SARS-CoV-2 omicron (B.1.1.529) variant wave in South Africa: a multicentre observational study.
    Cloete J; Kruger A; Masha M; du Plessis NM; Mawela D; Tshukudu M; Manyane T; Komane L; Venter M; Jassat W; Goga A; Feucht U
    Lancet Child Adolesc Health; 2022 May; 6(5):294-302. PubMed ID: 35189083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing the feasibility of sustaining SARS-CoV-2 local containment in China in the era of highly transmissible variants.
    Wang Y; Sun K; Feng Z; Yi L; Wu Y; Liu H; Wang Q; Ajelli M; Viboud C; Yu H
    BMC Med; 2022 Nov; 20(1):442. PubMed ID: 36380354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 B.1.1.529 (Omicron) Variant - United States, December 1-8, 2021.
    CDC COVID-19 Response Team
    MMWR Morb Mortal Wkly Rep; 2021 Dec; 70(50):1731-1734. PubMed ID: 34914670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection for infectivity profiles in slow and fast epidemics, and the rise of SARS-CoV-2 variants.
    Blanquart F; Hozé N; Cowling BJ; Débarre F; Cauchemez S
    Elife; 2022 May; 11():. PubMed ID: 35587653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An updated review of epidemiological characteristics, immune escape, and therapeutic advances of SARS-CoV-2 Omicron XBB.1.5 and other mutants.
    Liu Z; Li J; Pei S; Lu Y; Li C; Zhu J; Chen R; Wang D; Sun J; Chen K
    Front Cell Infect Microbiol; 2023; 13():1297078. PubMed ID: 38156316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Omicron and Delta variant of SARS-CoV-2: A comparative computational study of spike protein.
    Kumar S; Thambiraja TS; Karuppanan K; Subramaniam G
    J Med Virol; 2022 Apr; 94(4):1641-1649. PubMed ID: 34914115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
    Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.
    Madewell ZJ; Yang Y; Longini IM; Halloran ME; Dean NE
    JAMA Netw Open; 2022 Apr; 5(4):e229317. PubMed ID: 35482308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.
    Rathinasamy M; Kandhasamy S
    J Med Virol; 2022 Jun; 94(6):2414-2421. PubMed ID: 35112734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has Omicron Changed the Evolution of the Pandemic?
    Lundberg AL; Lorenzo-Redondo R; Ozer EA; Hawkins CA; Hultquist JF; Welch SB; Prasad PVV; Oehmke JF; Achenbach CJ; Murphy RL; White JI; Havey RJ; Post LA
    JMIR Public Health Surveill; 2022 Jan; 8(1):e35763. PubMed ID: 35072638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Booster BNT162b2 COVID-19 Vaccination Increases Neutralizing Antibody Titers Against the SARS-CoV-2 Omicron Variant in Both Young and Elderly Adults.
    Um J; Choi YY; Kim G; Kim MK; Lee KS; Sung HK; Kim BC; Lee YK; Jang HC; Bang JH; Chung KH; Oh MD; Park JS; Jeon J
    J Korean Med Sci; 2022 Mar; 37(9):e70. PubMed ID: 35257525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.